Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.
J Thromb Thrombolysis
; 30(2): 215-9, 2010 Aug.
Article
in En
| MEDLINE
| ID: mdl-20419336
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Peptides
/
Blood Coagulation
/
Blood Coagulation Tests
/
Chromogenic Compounds
/
Venous Thromboembolism
/
Fibrinolytic Agents
Type of study:
Clinical_trials
/
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Thromb Thrombolysis
Journal subject:
ANGIOLOGIA
Year:
2010
Document type:
Article
Affiliation country:
Italy
Country of publication:
Netherlands